ITOS iTeos Therapeutics Inc Total Asset Value of Company
The asset value reflected in the pakistan chart helps assess the expansion of iTeos Therapeutics (ITOS) within the immuno-oncology sector through its partnership with GSK, where total resources amount to 687.53. The diversification of research centers supports the stability of scientific work. However, geopolitical tensions and sanctions are creating a shortage of reagents, which slows down international certification and the conduct of trials for new drugs.
Analytical breakdowns and data insights for company iTeos (ITOS)
- current quotes and average value forecast:
- market capitalization data:
- issuer book value statistics:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio iTeos Therapeutics|ITOS - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio iTeos Pharma|ITOS - Company Aggregate Debts|Debts to Book Capitalization iTeos Pharma|ITOS - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings iTeos Therapeutics|Interim Coverage Ratio iteostherapeutics.com
- net income and valuation multiples indicators:
Fundamental valuation:iTeos Therapeutics
When assessing the financial stability of iTeos Therapeutics (ITOS), it is essential to understand that the total resources, reverse-calculated via Return on Assets (ROA), reflect the actual fundamental strength of the business, which is demonstrated on GURU.Markets by the growth of assets and resources. This indicator allows investors to filter out market noise, confirming the efficient use of joint capital with a global pharma leader to fund costly clinical trials of innovative antibodies.
Key competitors
ARGX - Company Total Asset Base|Aggregate Company Assets BioNTech|Abivax - Total Asset Value of Company|Company Total Assets ADMA|PTGX (Protagonist Corp) - Aggregate Asset Value|Company Total Assets IMVT (Immunovant, Inc.)|Company Total Assets kiniksa.com KNSA|GRFS - Aggregate Company Assets|Aggregate Asset Value ADPT (Adaptive Biotech)|Celldex (CLDX) - Aggregate Company Assets|Cumulative Company Assets Aurinia Corp|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com|Cumulative Company Assets DNTH (Dianthus Therapeutics, Inc.)|PHVS (Pharvaris NV) - Aggregate Asset Value|Company Total Assets ABCL (abcellera.com)|Company Total Asset Base Tourmaline (TRML)|PGEN - Aggregate Company Assets|pharming.com (PHAR) - Cumulative Company Assets|Nektar Therapeutics Inc. (NKTR) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|Cumulative Company Assets ZBIO|Company Total Assets Immunome Bio|Aggregate Company Assets Gossamer Bio, Inc. (GOSS)|kalvista.com - Total Business Assets|Company Total Assets SEPN (Septerna)|Pieris Pharma (PVLA) - Company Assets|Savara Corp - Company Total Assets|Company Total Asset Base Rigel Corp RIGL|ANAB (AnaptysBio, Inc.) - Cumulative Company Assets|ATXS: Aggregate Business Assets|ENGN (enGene) - Company Total Assets|Company Assets RAPT Therapeutics Inc. RAPT|Aggregate Company Assets Aerovate Therapeutics Inc (JBIO)|ACRS - Company Assets|Aggregate Company Assets Kyverna Therapeutics KYTX|Company Total Asset Base tizianalifesciences.com (TLSA)|CABA: Cumulative Company Assets|Aggregate Asset Value VTYX (Ventyx Biosciences Inc.)|THTX (Theratechnologies Inc) - Cumulative Company Assets|AVTX: Aggregate Business Assets|ELDN (Eledon Pharmaceuticals) - Company Total Assets|AGEN: Aggregate Asset Value|Company Total Assets CLYM|ZURA - Company Assets|Aggregate Company Assets aTyr ATYR|Aggregate Asset Value ADAG|Ikena Oncology, Inc. - Company Total Assets|STTK - Company Total Assets|equilliumbio.com (EQ) - Aggregate Company Assets|Total Asset Value of Company CNTB (Connect Biopharma Holdings Limited)|IMUX (Immunic Therapeutics) - Company Total Assets|Company Assets Atara Biotherapeutics Inc ATRA|Cumulative Company Assets IFRX (InflaRx N.V.)|Company Total Assets x4pharma.com (XFOR)|Adicet Bio, Inc. - Cumulative Company Assets|Aggregate Business Assets CELU (Celularity Inc)|INmune Bio Corp - Company Total Assets|Company Total Asset Base Barinthus Biotherapeutics Corp BRNS|KZR: Company Total Assets|Cumulative Company Assets sabbiotherapeutics.com|Aggregate Company Assets Akari Therapeutics Plc|Enlivex Therapeutics, Ltd. (ENLV) - Company Total Asset Base|Company Total Assets QTTB|Company Total Asset Base GeoVax Corp|Edesa Biotech, Inc. - Cumulative Company Assets|Aggregate Business Assets IBIO (ibioinc.com)|CARM - Aggregate Company Assets|Company Assets XTL Biopharmaceuticals Ltd|boltbio.com (BOLT) - Aggregate Company Assets|HCWB - Company Total Asset Base|Aggregate Company Assets Aptevo Therapeutics, Inc.|AIM ImmunoTech, Inc. - Total Asset Value of Company|Company Total Assets ADTX|GRI (GRI Bio Inc) - Aggregate Asset Value|Company Total Assets XRTX (XORTX)|Company Total Assets Vyome Therapeutics HIND|REVB - Aggregate Company Assets|Aggregate Asset Value INDP (indaptusrx.com)|Scinai Immunotherapeutics Ltd. (SCNI) - Aggregate Company Assets|Cumulative Company Assets CalciMedica|AFMD (Affimed NV) - Company Total Assets|Company Total Assets Allakos Therapeutics|Cumulative Company Assets HOOK (HOOKIPA Pharma Inc.)|IGMS (igmbio.com) - Aggregate Asset Value|Company Total Assets OCEA (Ocean Biomedical)|Company Total Asset Base TC BioPharm (Holdings) Plc (TCBP)|THRD - Aggregate Company Assets